Steps Forward for Cardio-Kidney-Metabolic Research in Transplant Recipients.
作者信息
Clemens Kristin K, Moist Louise M
机构信息
Division of Endocrinology and Metabolism, Department of Medicine, Western University, London, Ontario, Canada.
Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
出版信息
Kidney360. 2025 May 1;6(5):694-695. doi: 10.34067/KID.0000000796.
Abstract
摘要
相似文献
1
Steps Forward for Cardio-Kidney-Metabolic Research in Transplant Recipients.移植受者心肺代谢研究取得进展
Kidney360. 2025 May 1;6(5):694-695. doi: 10.34067/KID.0000000796.
2
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney Transplantation: A Population Cohort Study.糖尿病对移植前血管疾病与肾移植后长期移植和患者结局关联的影响：一项基于人群的队列研究。
Am J Kidney Dis. 2018 Jan;71(1):102-111. doi: 10.1053/j.ajkd.2017.08.018. Epub 2017 Nov 28.
3
[Metabolic syndrome after kidney transplantation].肾移植后的代谢综合征
Vnitr Lek. 2014 Mar;60(3):196-204.
4
Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in France.胰岛-肾联合移植与单纯肾移植治疗 1 型糖尿病肾移植受者（KAIAK）：法国基于人群的目标模拟试验。
Lancet Diabetes Endocrinol. 2024 Oct;12(10):716-724. doi: 10.1016/S2213-8587(24)00241-9. Epub 2024 Sep 6.
5
GLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study.胰高血糖素样肽-1受体激动剂在已有糖尿病的肾移植受者中的应用：一项回顾性队列研究
Lancet Diabetes Endocrinol. 2025 May;13(5):374-383. doi: 10.1016/S2213-8587(24)00371-1. Epub 2025 Mar 5.
6
Glycated albumin and post-transplant diabetes mellitus in kidney transplant recipients.肾移植受者中的糖化白蛋白与移植后糖尿病
Ann Clin Biochem. 2023 Mar;60(2):109-116. doi: 10.1177/00045632231152074. Epub 2023 Jan 14.
7
Increased ferritin levels are associated with incident diabetes after kidney transplantation: A prospective cohort study.
Diabetes Metab. 2025 Mar;51(2):101626. doi: 10.1016/j.diabet.2025.101626. Epub 2025 Feb 15.
8
The 25-hydroxyvitamin D level in Kidney Transplant Recipients and Its Association With Renal Function and Other Cardio-Metabolic Risk Markers.肾移植受者 25-羟维生素 D 水平及其与肾功能和其他心血管代谢风险标志物的关系。
Transplant Proc. 2024 Apr;56(3):557-560. doi: 10.1016/j.transproceed.2024.02.012. Epub 2024 Mar 20.
9
Cholelithiasis in pancreas and kidney transplant recipients with diabetes.糖尿病胰腺和肾移植受者的胆石症
Surgery. 1993 Oct;114(4):858-63; discussion 863-4.
10
Changes in glucose metabolism among recipients with diabetes 1 year after kidney transplant: a multicenter 1-year prospective study.糖尿病受者肾移植后 1 年葡萄糖代谢变化：一项多中心前瞻性 1 年研究。
Front Endocrinol (Lausanne). 2023 Jun 21;14:1197475. doi: 10.3389/fendo.2023.1197475. eCollection 2023.
本文引用的文献
1
Safety and Efficacy of Liraglutide and Semaglutide in Kidney Transplant Recipients.利拉鲁肽和司美格鲁肽在肾移植受者中的安全性和有效性
Kidney360. 2025 May 1;6(5):848-850. doi: 10.34067/KID.0000000706. Epub 2025 Jan 23.
2
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis.胰高血糖素样肽-1受体激动剂在肾移植受者中的安全性和有效性：一项系统评价和荟萃分析。
Clin Kidney J. 2024 Feb 2;17(2):sfae018. doi: 10.1093/ckj/sfae018. eCollection 2024 Feb.
3
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis.肥胖症且无糖尿病个体中胰高血糖素样肽-1 受体激动剂对体重和心血管代谢参数的疗效和安全性：系统评价和荟萃分析。
Endocr Pract. 2024 Feb;30(2):160-171. doi: 10.1016/j.eprac.2023.11.007. Epub 2023 Nov 27.
4
Glucagon-like peptide 1 receptor agonists in end-staged kidney disease and kidney transplantation: A narrative review.终末期肾病和肾移植中的胰高血糖素样肽-1受体激动剂：一项叙述性综述。
Nutr Metab Cardiovasc Dis. 2023 Jun;33(6):1111-1120. doi: 10.1016/j.numecd.2023.03.023. Epub 2023 Apr 5.
5
Effect of glucagon-like peptide 1 receptor agonists on albuminuria in adult patients with type 2 diabetes mellitus: A systematic review and meta-analysis.胰高血糖素样肽-1 受体激动剂对 2 型糖尿病成年患者蛋白尿的影响：系统评价和荟萃分析。
Diabetes Obes Metab. 2022 Sep;24(9):1869-1881. doi: 10.1111/dom.14776. Epub 2022 Jun 6.
6
Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data.使用胰高血糖素样肽-1受体激动剂后的低血糖症：上市后监测数据的真实世界分析
Ann Transl Med. 2021 Sep;9(18):1482. doi: 10.21037/atm-21-4162.
7
Liraglutide-induced acute kidney injury.利拉鲁肽引起的急性肾损伤。
Pharmacotherapy. 2012 Jan;32(1):e7-11. doi: 10.1002/PHAR.1014.
8
Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.胰高血糖素样肽-1 受体激动剂激活啮齿动物甲状腺 C 细胞，导致降钙素释放和 C 细胞增殖。
Endocrinology. 2010 Apr;151(4):1473-86. doi: 10.1210/en.2009-1272. Epub 2010 Mar 4.
Zotero 插件